Gilead says remdesivir shows improvement in COVID 19 patients when used early

over 5 years in nationalpost

Gilead Sciences Inc’s experimental antiviral drug remdesivir helped improve symptoms in COVID-19 patients who were given the drug early than among those who were treated later, the company said. The closely-watched drug has moved markets in the past few weeks and on Wednesday broader markets once again rose on the data and Gilead shares also […]

Mentioned in this news
Share it on